Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

EWS/Fli-1 chimeric protein is a transcriptional activator.

Ohno T, Rao VN, Reddy ES.

Cancer Res. 1993 Dec 15;53(24):5859-63.

PMID:
7503813
2.

Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.

Lessnick SL, Braun BS, Denny CT, May WA.

Oncogene. 1995 Feb 2;10(3):423-31.

PMID:
7845667
3.

Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.

Rao VN, Ohno T, Prasad DD, Bhattacharya G, Reddy ES.

Oncogene. 1993 Aug;8(8):2167-73.

PMID:
8336942
5.

SRE elements are binding sites for the fusion protein EWS-FLI-1.

Magnaghi-Jaulin L, Masutani H, Robin P, Lipinski M, Harel-Bellan A.

Nucleic Acids Res. 1996 Mar 15;24(6):1052-8.

6.

Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.

Ouchida M, Ohno T, Fujimura Y, Rao VN, Reddy ES.

Oncogene. 1995 Sep 21;11(6):1049-54.

PMID:
7566963
7.
8.

Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.

Athanasiou M, LeGallic L, Watson DK, Blair DG, Mavrothalassitis G.

Cancer Gene Ther. 2000 Aug;7(8):1188-95.

9.

Fli-1b is generated by usage of differential splicing and alternative promoter.

Dhulipala PD, Lee L, Rao VN, Reddy ES.

Oncogene. 1998 Sep 3;17(9):1149-57.

10.

The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.

Mao X, Miesfeldt S, Yang H, Leiden JM, Thompson CB.

J Biol Chem. 1994 Jul 8;269(27):18216-22.

11.

Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.

Sorensen PH, Shimada H, Liu XF, Lim JF, Thomas G, Triche TJ.

Cancer Res. 1995 Mar 15;55(6):1385-92.

12.

Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.

Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES.

Oncogene. 1997 Mar 20;14(11):1259-68.

13.

A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.

Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN.

Oncogene. 1995 Mar 16;10(6):1229-34.

PMID:
7700648
14.

A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.

Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT.

Nat Genet. 1994 Feb;6(2):146-51.

PMID:
8162068
15.
16.

EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.

Kovar H, Aryee DN, Jug G, Henöckl C, Schemper M, Delattre O, Thomas G, Gadner H.

Cell Growth Differ. 1996 Apr;7(4):429-37.

17.

The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.

Bertolotti A, Bell B, Tora L.

Oncogene. 1999 Dec 23;18(56):8000-10.

18.

EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.

Thompson AD, Braun BS, Arvand A, Stewart SD, May WA, Chen E, Korenberg J, Denny C.

Oncogene. 1996 Dec 19;13(12):2649-58.

PMID:
9000139
19.

A new member of the ETS family fused to EWS in Ewing tumors.

Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H, Delattre O.

Oncogene. 1997 Mar 13;14(10):1159-64.

20.

[Detection of EWS-/FLI-1 gene fusion transcripts by RT-PCR as a tool in the diagnosis of tumors of the Ewing sarcoma group].

Dockhorn-Dworniczak B, Schäfer KL, Dantcheva R, Blasius S, van Valen F, Burdach S, Winkelmann W, Jürgens J, Böcker W.

Verh Dtsch Ges Pathol. 1994;78:214-9. German.

PMID:
7533989

Supplemental Content

Support Center